|
names
|
- "16,(17)-EPOXY-4(Z),7(Z),10(Z),13(Z),19(Z)-DPA"
- (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,11α,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid
- Dinoprostone
- Dinoprostone 100 microg/mL in Acetonitrile
- Dinoprostone, European Pharmacopoeia (EP) Reference Standard
- Dinoprostone, United States Pharmacopeia (USP) Reference Standard
- Prostaglandin E2
- Prostaglandin E2, >=93% (HPLC), synthetic
- Prostaglandin E2, gamma-irradiated, powder, BioXtra, suitable for cell culture
- Prostaglandin E2 (GMP)
- Prostaglandin E2 (PGE2)
- Prostaglandin E2 (Standard)
- Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture
- (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid
|